
Gemimet Extended-Release Tablet 25/1000 mg
34.45mg
Tablet · Prescription medication · Combination
LG Chem, Ltd.
Gemigliptin Tartrate 1.5 HCl is a diabetes treatment ingredient used for blood sugar control.
MFDS ingredient code M263103
Gemigliptin Tartrate 1.5 HCl is a diabetes medication belonging to the DPP-4 inhibitor class. This ingredient is used to lower blood sugar by promoting insulin secretion and inhibiting blood sugar rise.
This ingredient inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. As a result, insulin secretion increases and blood sugar is regulated, helping to alleviate diabetes symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Gemigliptin has higher selectivity and a longer duration compared to other DPP-4 inhibitors, allowing for effective maintenance with once-daily dosing. Additionally, dosage adjustment based on kidney function is relatively straightforward.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.